Evaluation of Vascular Toxicity of Immune Checkpoint Inhibitors in Patients Head and Neck or Lung Cancer
NCT05655663
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Head and Neck Cancer
Lung Cancer
Interventions
OTHER:
Vascular investigation
Sponsor
Centre Henri Becquerel